BridgeMD
Tests treatment safety and results for Dyspareunia
Official title Effectiveness of Radiofrequency Combined With Ultrasound for the Treatment of Postpartum Dyspareunia
ClinicalTrials.gov ID: NCT07504991
What this study is testing
- What it's testing
- The objective of this community-based, non-randomized, quasi-experimental study is to assess the effectiveness of BTL EXILIS technology-based on combined radiofrequency and ultrasound-in women of childbearing age from an industrialized country with a diagnosis of dyspareunia following vaginal delivery. The primary research question is: \- Do patients experience a resolution of pain during sexual intercourse after completing the treatment?
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50, women only
You may be able to join if
- Women of childbearing age
- Medical history of at least one prior vaginal delivery
- Reported persistent pain during penetrative sexual intercourse
- Meeting the clinical criteria for dyspareunia
- Moderate to severe pain level, defined as a score of 4 or higher on the Visual Analogue Scale (VAS 0-10)
You likely can't join if
- Contraindications to the study treatment. Women with any medical condition that precludes the use of the study technology
- Non-postpartum dyspareunia
See the full eligibility criteria
- Women of childbearing age
- Medical history of at least one prior vaginal delivery
- Reported persistent pain during penetrative sexual intercourse
- Meeting the clinical criteria for dyspareunia
- Moderate to severe pain level, defined as a score of 4 or higher on the Visual Analogue Scale (VAS 0-10)
- Eligible patients must demonstrate a moderate to severe pain level, defined as a VAS score of 4 or higher
- No restriction on the time elapsed between the last delivery and the current clinical diagnosis.
- Contraindications to the study treatment. Women with any medical condition that precludes the use of the study technology
- Non-postpartum dyspareunia
The study team makes the final eligibility decision.
Where it's taking place
- Tarragona, TARRAGONA, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tarragona, TARRAGONA, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.